NasdaqGS - Nasdaq Real Time Price USD
uniQure N.V. (QURE)
15.39
+0.68
+(4.62%)
As of 1:52:26 PM EDT. Market Open.
Major Holders
Breakdown | |
---|---|
8.29% | % of Shares Held by All Insider |
92.12% | % of Shares Held by Institutions |
100.44% | % of Float Held by Institutions |
171 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Vestal Point Capital, LP | 4.79M | Mar 31, 2025 | 8.75% | 73,757,684 |
RTW Investments LP | 4.27M | Mar 31, 2025 | 7.79% | 65,644,938 |
EcoR1 Capital, LLC | 3.99M | Mar 31, 2025 | 7.28% | 61,390,265 |
Nantahala Capital Management, LLC | 2.76M | Mar 31, 2025 | 5.03% | 42,414,256 |
Aberdeen Group plc | 2.22M | Mar 31, 2025 | 4.04% | 34,097,330 |
Avoro Capital Advisors LLC | 2.17M | Mar 31, 2025 | 3.97% | 33,473,250 |
Franklin Resources, Inc. | 1.99M | Mar 31, 2025 | 3.63% | 30,590,519 |
683 Capital Management LLC | 1.55M | Mar 31, 2025 | 2.83% | 23,854,500 |
Blackrock Inc. | 1.44M | Mar 31, 2025 | 2.62% | 22,115,138 |
Integral Health Asset Management, LLC | 1.25M | Mar 31, 2025 | 2.28% | 19,237,500 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | 987.12k | Apr 30, 2025 | 1.80% | 15,191,823 |
abrdn Healthcare Investors | 812.69k | Dec 31, 2024 | 1.48% | 12,507,314 |
Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 733.5k | Jan 31, 2025 | 1.34% | 11,288,565 |
Delaware Group Equity Funds IV-Macquarie Healthcare Fund | 706.17k | Dec 31, 2024 | 1.29% | 10,867,894 |
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 698.69k | Dec 31, 2024 | 1.28% | 10,752,808 |
Fidelity Select Portfolios-Biotechnology Portfolio | 421.28k | Mar 31, 2025 | 0.77% | 6,483,530 |
Fidelity Select Portfolios-Pharmaceuticals Portfolio | 405.3k | Mar 31, 2025 | 0.74% | 6,237,567 |
abrdn Life Sciences Investors | 398.32k | Dec 31, 2024 | 0.73% | 6,130,083 |
Columbia Funds Series Trust I-Columbia Small Cap Value Fund I | 388.49k | Jan 31, 2025 | 0.71% | 5,978,861 |
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 348.4k | Mar 31, 2025 | 0.64% | 5,361,876 |
Related Tickers
RGNX REGENXBIO Inc.
9.83
+0.41%
SLDB Solid Biosciences Inc.
2.8750
-0.86%
LXEO Lexeo Therapeutics, Inc.
3.4400
+4.56%
SRRK Scholar Rock Holding Corporation
31.13
+3.20%
ITOS iTeos Therapeutics, Inc.
8.38
-0.42%
CYTK Cytokinetics, Incorporated
32.05
+4.23%
SGMO Sangamo Therapeutics, Inc.
0.4999
+0.28%
RCKT Rocket Pharmaceuticals, Inc.
6.69
+3.64%
JANX Janux Therapeutics, Inc.
25.14
+4.01%
TVTX Travere Therapeutics, Inc.
17.59
+3.41%